Progressive Supranuclear Palsy (PSP)

Understanding Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is a rare neurological condition, comparable in frequency to ALS, that impacts balance, eye movements, and sometimes swallowing. It results from damage to brain cells responsible for coordination, thinking, and body movement. The condition is progressive, and over time, it can lead to severe issues like swallowing difficulties and aspiration pneumonia.
Early symptoms can include a tendency to fall backward. Patients often experience trouble with eye movements, particularly looking downward, which can cause double or blurred vision. This lack of eye contact may be misinterpreted as a lack of interest during conversations.
Overlap with Parkinson’s Disease
PSP can mimic and even overlap with Parkinson’s disease, leading to diagnostic challenges even for neurologists, as there is no definitive blood test or brain scan. The case of boxer Muhammad Ali is cited as an example where experts debated whether he had Parkinson’s complicated by head trauma or PSP. Both conditions can be associated with dementia and worsening symptoms over time.
Key symptoms of PSP include:
• Significant neck stiffness.
• Slow or slurred speech.
• Sensitivity to bright light.
• Swallowing difficulties, leading to gagging, choking, and pneumonia.
• Sleep disturbances and depression.
• A “surprised” or “frightened” facial expression due to muscle rigidity.
• Impulsive behaviors, such as inappropriate laughing or crying, which may indicate a pseudobulbar affect.
Treatment and Management
There is no specific cure for PSP. Treatment focuses on supportive care, including occupational and speech therapy, to manage symptoms. Medications may be prescribed to help with associated anxiety and depression.